Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-04

Clinical Trial Update: The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year [Phase 2]

View source ↗

Summary

Phase 2 trial comparing anti-HIV effects of saquinavir soft gelatin capsules to indinavir in patients previously treated with saquinavir hard capsules; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indinavir (indinavir)
  • saquinavir soft gelatin capsules (saquinavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED